The ability of intravitreal treatment with NT3 and the P75NTR neutralizing Ab to protect photoreceptors and inhibit microglial activation indicates that manipulation of neuronal-Müller cell-microglial interactions may be a novel strategy for neuroprotection in retinal disease. The gene discussed is NGFR; the disease is Abnormal retinal morphology.